![PDF) Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease PDF) Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease](https://i1.rgstatic.net/publication/322766866_Corrigendum_Exposure-efficacy_Relationships_for_Vedolizumab_Induction_Therapy_in_Patients_with_Ulcerative_Colitis_or_Crohn's_Disease/links/5d588141299bf151badcd9bb/largepreview.png)
PDF) Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn's Disease
![Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/04/Patient-Centricity-in-IBD-Treatment-An-Interview-with-Dr-Corey-Siegel-at-the-13th-Congress-of-ECCO.jpg)
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Journal
![PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany](https://i1.rgstatic.net/publication/337008399_4th_Congress_of_ECCO_-_Inflammatory_Bowel_Diseases_Impact_of_anti-TNF_treatment_on_Extra-intestinal_Manifestations_in_Patients_with_Inflammatory_Bowel_Disease_real_world_data_in_Germany/links/5dc01db392851c818028b1a3/largepreview.png)
PDF) 4th Congress of ECCO Inflammatory Bowel Diseases Impact of antiTNF treatment on Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: real world data in Germany
![Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2022/03/Feature-Image-Gastroenterology-11-Supplement-1-ECCO.jpg)
Review of the 17th Congress of the European Crohn's and Colitis Organisation (ECCO) - European Medical Journal
![European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine](https://kongres-magazine.eu/wp-content/uploads/2017/02/IMG_4737-800x600.jpg)
European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine
![Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook - European Medical Journal Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook - European Medical Journal](https://www.emjreviews.com/wp-content/uploads/2018/06/New-Website-Photographs-EMJ-3.2-940x564.jpg)
Anti-Tumour Necrosis Factor in Inflammatory Bowel Disease: Inventory and Outlook - European Medical Journal
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/Vytenis-Andriukaitis-EU-Health-Commissioner-speaking-at-ECCO2017.jpg)